Back to News
Activism

Activist Investing Today: Axler Talks Forescout, Forensics

|
Published: July 17th, 2020
The activist short seller behind Spruce Point Capital offers a behind-the-scenes look at two campaigns and his investigative approach to companies, which includes running background checks on executives and directors as well as working with private investigators.

When Forescout Technologies Inc. (FSCT) filed suit in May to hold Advent International Corp. to its $1.9 billion privatization acquisition, shares of the cybersecurity company fell sharply.

Watching closely was Spruce Point Capital Management LLC’s Ben Axler, an activist short seller, who appears on The Deal’s latest installment of the Activist Investing Today podcast. In the interview he talks about why it became obvious to him much earlier that the deal “didn’t reflect the high probability that the transaction could be renegotiated.”

“Forescout struck a deal with Advent before the [World Health Organization] had declared Covid a pandemic,” Axler said. “We took a look at all the deals that had been announced in January, February and early March, when the market was robust and valuations were rich, and it became obvious to us after reviewing Forescout’s business that there was certainly room for that share price to come down to reflect the new reality. Our projections were more pessimistic than the projections indicated in the proxy statement that Forescout gave to investors.”

Axler also spoke about activism in the middle market, his latest campaign at Prestige Consumer Healthcare Inc. (PBH) as well as Spruce Point’s “forensic” approach to activism, which includes running background checks on executives and directors as well as working with private investigators.

“We try to identify companies that use aggressive financial presentation accounting methods, poor governance and misalignments with shareholders and, in extreme cases, try to find companies that are misrepresenting their products — and in the most extreme cases trying to commit some fraud,” Axler said. “We’re looking for areas where management or board members have omitted key aspects of their bios that would have led investors to see that they failed in prior business efforts.”

Axler is also set to participate on The Deal’s “Middle-Market Activism Amidst Covid-19″ webcast on July 27 at 1 p.m. The short-seller insurgent will join Barington Capital’s Jim Mitarotonda, Snow Park Capital Partners LP’s Jeffrey Pierce and Coast Capital LLC’s James Rasteh, all of whom will offer their thoughts on the changing tactics of activist managers facing coronavirus-driven challenges.

Here’s the Podcast:

Check out more Activist Investing Today podcasts featuring the panelists:

More podcasts from The Deal are available on iTunesSpotify and SoundCloud and on TheDeal.com.

More From Activism

Activism

TDE Middle Market: Pro-ESG Doesn't Mean Anti-Profits

By Nikitha Sattiraju
|
Published: July 31st, 2020
ESG investing is less about checking boxes to screen companies and more about engaging them on sustainability goals to drive long-term growth and returns to investors, a panel of ESG investors said at The Deal Economy: Middle Market Week.
Activism

TDE Middle Market: Activists Eye Pay During Covid

By Greg Morcroft
|
Published: July 30th, 2020
Companies that were unprepared for the coronavirus due to too-cozy relationships between board and management could become the next targets, panelists said during an activist webcast, part of The Deal Economy: Middle Market Week.